This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ICAD Announces Distribution Agreement With Hitachi For MR Image Analysis And Guided Biopsy Solution

iCAD, Inc.(Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, today announced that it has entered into a distribution agreement with Hitachi Medical Systems. With this agreement, iCAD’s SpectraLook with PrecisionPoint image analysis solution for breast MRI will be available for purchase with Hitachi’s Oasis and Echelon MRI systems. iCAD’s MRI solution will assist radiologists in distinguishing potential cancers in the breast as part of their overall analysis of MRI studies and streamline the planning and performance of MRI-guided percutaneous breast biopsies.

“Dynamic MRI is being utilized with increased frequency as a less-invasive way to identify cancer at an early stage,” said Ken Ferry, President and CEO of iCAD. “With this agreement, iCAD’s advanced image analysis technology will be available to assist the many clinicians using Hitachi’s MR systems to increase diagnostic confidence – allowing them to more accurately and quickly assess a tumor, which should lead to more targeted treatment options for their patients.”

iCAD’s SpectraLook MR image analysis solution provides objective consistent quantitative analysis of breast MRI datasets creating colorized images based on signal changes defined by tumor physiology. This unique technology is designed to assist radiologists in distinguishing potential cancers in the breast as part of their overall analysis of MRI studies. When coupled with VersaVue ® Enterprise, iCAD’s image review and analysis software, this comprehensive solution improves the analysis workflow, interventional planning and reporting of breast MRI results while streamlining the radiologist’s workflow and diagnosis. The PrecisionPoint software is an integrated module within VersaVue Enterprise which provides radiologists with an automatic calculation of the location and depth of a targeted region of interest making MRI-guided breast biopsies easier, faster and more reliable.

“Our partnership with iCAD brings together two of the most advanced imaging technologies that will further advance the world of MRI breast cancer diagnosis and guided biopsy,” said Sheldon Schaffer, Vice President and General Manager of MRI and CT for Hitachi. “Combining iCAD’s advanced image analysis technologies with the power of Hitachi’s scanners gives radiologists a more controlled, faster and accurate way to locate and sample lesions in the breast.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,732.22 -66.27 -0.37%
S&P 500 2,081.76 -8.35 -0.40%
NASDAQ 5,106.9150 -20.61 -0.40%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs